BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 35392973)

  • 1. ZMAT1 acts as a tumor suppressor in pancreatic ductal adenocarcinoma by inducing SIRT3/p53 signaling pathway.
    Ma Z; Li Z; Wang S; Zhou Z; Liu C; Zhuang H; Zhou Q; Huang S; Zhang C; Hou B
    J Exp Clin Cancer Res; 2022 Apr; 41(1):130. PubMed ID: 35392973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-708-5p inhibits the progression of pancreatic ductal adenocarcinoma by targeting Sirt3.
    Huang S; Guo H; Cao Y; Xiong J
    Pathol Res Pract; 2019 Apr; 215(4):794-800. PubMed ID: 30683474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. YY1 suppresses proliferation and migration of pancreatic ductal adenocarcinoma by regulating the CDKN3/MdM2/P53/P21 signaling pathway.
    Liu D; Zhang J; Wu Y; Shi G; Yuan H; Lu Z; Zhu Q; Wu P; Lu C; Guo F; Chen J; Jiang K; Miao Y
    Int J Cancer; 2018 Apr; 142(7):1392-1404. PubMed ID: 29168185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-29b-2-5p inhibits cell proliferation by directly targeting Cbl-b in pancreatic ductal adenocarcinoma.
    Li C; Dong Q; Che X; Xu L; Li Z; Fan Y; Hou K; Wang S; Qu J; Xu L; Wen T; Yang X; Qu X; Liu Y
    BMC Cancer; 2018 Jun; 18(1):681. PubMed ID: 29940895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pancreatic Cancer Progression Relies upon Mutant p53-Induced Oncogenic Signaling Mediated by NOP14.
    Du Y; Liu Z; You L; Hou P; Ren X; Jiao T; Zhao W; Li Z; Shu H; Liu C; Zhao Y
    Cancer Res; 2017 May; 77(10):2661-2673. PubMed ID: 28280038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upregulation of amplified in breast cancer 1 contributes to pancreatic ductal adenocarcinoma progression and vulnerability to blockage of hedgehog activation.
    Li L; Bao J; Wang H; Lei JH; Peng C; Zeng J; Hao W; Zhang X; Xu X; Yu C; Deng CX; Chen Q
    Theranostics; 2021; 11(4):1672-1689. PubMed ID: 33408774
    [No Abstract]   [Full Text] [Related]  

  • 7. SETDB1 Inhibits p53-Mediated Apoptosis and Is Required for Formation of Pancreatic Ductal Adenocarcinomas in Mice.
    Ogawa S; Fukuda A; Matsumoto Y; Hanyu Y; Sono M; Fukunaga Y; Masuda T; Araki O; Nagao M; Yoshikawa T; Goto N; Hiramatsu Y; Tsuda M; Maruno T; Nakanishi Y; Hussein MS; Tsuruyama T; Takaori K; Uemoto S; Seno H
    Gastroenterology; 2020 Aug; 159(2):682-696.e13. PubMed ID: 32360551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-143-3p suppresses tumorigenesis in pancreatic ductal adenocarcinoma by targeting KRAS.
    Xie F; Li C; Zhang X; Peng W; Wen T
    Biomed Pharmacother; 2019 Nov; 119():109424. PubMed ID: 31521891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-615-5p is epigenetically inactivated and functions as a tumor suppressor in pancreatic ductal adenocarcinoma.
    Gao W; Gu Y; Li Z; Cai H; Peng Q; Tu M; Kondo Y; Shinjo K; Zhu Y; Zhang J; Sekido Y; Han B; Qian Z; Miao Y
    Oncogene; 2015 Mar; 34(13):1629-40. PubMed ID: 24769899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-377 inhibits the proliferation of pancreatic cancer by targeting Pim-3.
    Chang W; Liu M; Xu J; Fu H; Zhou B; Yuan T; Chen P
    Tumour Biol; 2016 Nov; 37(11):14813-14824. PubMed ID: 27638830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ARF tumor suppressor inhibits tumor cell colonization independent of p53 in a novel mouse model of pancreatic ductal adenocarcinoma metastasis.
    Muniz VP; Barnes JM; Paliwal S; Zhang X; Tang X; Chen S; Zamba KD; Cullen JJ; Meyerholz DK; Meyers S; Davis JN; Grossman SR; Henry MD; Quelle DE
    Mol Cancer Res; 2011 Jul; 9(7):867-77. PubMed ID: 21636682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paraoxonase 2 Facilitates Pancreatic Cancer Growth and Metastasis by Stimulating GLUT1-Mediated Glucose Transport.
    Nagarajan A; Dogra SK; Sun L; Gandotra N; Ho T; Cai G; Cline G; Kumar P; Cowles RA; Wajapeyee N
    Mol Cell; 2017 Aug; 67(4):685-701.e6. PubMed ID: 28803777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Linc00511 acts as a competing endogenous RNA to regulate VEGFA expression through sponging hsa-miR-29b-3p in pancreatic ductal adenocarcinoma.
    Zhao X; Liu Y; Li Z; Zheng S; Wang Z; Li W; Bi Z; Li L; Jiang Y; Luo Y; Lin Q; Fu Z; Rufu C
    J Cell Mol Med; 2018 Jan; 22(1):655-667. PubMed ID: 28984028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The circadian clock gene Bmal1 acts as a potential anti-oncogene in pancreatic cancer by activating the p53 tumor suppressor pathway.
    Jiang W; Zhao S; Jiang X; Zhang E; Hu G; Hu B; Zheng P; Xiao J; Lu Z; Lu Y; Ni J; Chen C; Wang X; Yang L; Wan R
    Cancer Lett; 2016 Feb; 371(2):314-25. PubMed ID: 26683776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ETV4 promotes pancreatic ductal adenocarcinoma metastasis through activation of the CXCL13/CXCR5 signaling axis.
    Gao X; Jiang M; Chu Y; Han Y; Jin Y; Zhang W; Wang W; Yang S; Li W; Fan A; Cao J; Wang J; Liu H; Fu X; Chen D; Nie Y; Fan D
    Cancer Lett; 2022 Jan; 524():42-56. PubMed ID: 34582976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EFNB2 facilitates cell proliferation, migration, and invasion in pancreatic ductal adenocarcinoma via the p53/p21 pathway and EMT.
    Zhu F; Dai SN; Xu DL; Hou CQ; Liu TT; Chen QY; Wu JL; Miao Y
    Biomed Pharmacother; 2020 May; 125():109972. PubMed ID: 32036221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primate-specific miRNA-637 inhibited tumorigenesis in human pancreatic ductal adenocarcinoma cells by suppressing Akt1 expression.
    Xu RL; He W; Tang J; Guo W; Zhuang P; Wang CQ; Fu WM; Zhang JF
    Exp Cell Res; 2018 Feb; 363(2):310-314. PubMed ID: 29366808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-561-5p Inhibits Cell Proliferation and Invasion by Targeting RAC1 in Pancreatic Ductal Adenocarcinoma.
    Xi B; Lai M; Zhang W; Wang F
    Ann Clin Lab Sci; 2022 Mar; 52(2):213-221. PubMed ID: 35414500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulated circular RNA circ_0007534 indicates an unfavorable prognosis in pancreatic ductal adenocarcinoma and regulates cell proliferation, apoptosis, and invasion by sponging miR-625 and miR-892b.
    Hao L; Rong W; Bai L; Cui H; Zhang S; Li Y; Chen D; Meng X
    J Cell Biochem; 2019 Mar; 120(3):3780-3789. PubMed ID: 30382592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Novel SLRP Family Member Lumican Suppresses Pancreatic Cancer Cell Growth.
    Gao H; Liu C; Ren Q; Zhang L; Qin W; Wang H; Zhang Y
    Pancreas; 2023 Jan; 52(1):e29-e36. PubMed ID: 37378898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.